2026 I. Jolanda M. de Vries: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	83	1462	1333	54	53	235	22822

Overview

I. Jolanda M. de Vries is affiliated with Radboud University in the Netherlands and has a significant body of work in medical research, particularly in the fields of immunology and oncology. Their research portfolio bridges core areas such as immunotherapy and immune responses, cancer immunotherapy and biomarkers, and immune cell function and interaction.

The main fields of study for de Vries include Medicine and Immunology and Microbiology, with a notable focus on the subfields of Immunology, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, and Surgery. The emphasis on immunotherapy and cancer-related immune studies is evident throughout their publication record.

The scientist's recent publications include:

Lactate dehydrogenase: a marker of diminished antitumor immunity (2020, OncoImmunology)
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer (2022, OncoImmunology)
The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture (2020, Nature Communications)
Subsets of CD1c+ DCs: Dendritic Cell Versus Monocyte Lineage (2020, Frontiers in Immunology)
Immunomodulatory aged neutrophils are augmented in blood and skin of psoriasis patients (2021, Journal of Allergy and Clinical Immunology)

The frequent venues where de Vries publishes work include:

Frontiers in Immunology
OncoImmunology
Nature Communications
Cancers
Journal for ImmunoTherapy of Cancer

Collaborations are a significant aspect of their research activities. Frequent co-authors include Mark A.J. Gorris, Carl G. Figdor, Gerty Schreibelt, Johannes Textor, and Georgina Flórez-Grau, reflecting interdisciplinary and extensive teamwork.

The work of de Vries spans important topics related to immune mechanisms and cancer, particularly:

Immunotherapy and Immune Responses
Cancer Immunotherapy and Biomarkers
Immune Cell Function and Interaction
CAR-T cell therapy research
T-cell and B-cell Immunology
Immune cells in cancer
Immune Response and Inflammation

Best Publications

Dendritic cell immunotherapy: mapping the way

Carl G Figdor;I Jolanda M de Vries;W Joost Lesterhuis;Cornelis J M Melief

1278
Citations
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy

I Jolanda M de Vries;W Joost Lesterhuis;Jelle O Barentsz;Pauline Verdijk

996
Citations
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

Paul J. Tacken;I. Jolanda M. de Vries;Ruurd Torensma;Carl G. Figdor

930
Citations
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state

I. Jolanda M. de Vries;Daniëlle J. E. B. Krooshoop;Nicole M. Scharenborg;W. Joost Lesterhuis

624
Citations
The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells.

Alessandra Cambi;Karlijn Gijzen;I. Jolanda M. de Vries;Ruurd Torensma

498
Citations
Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics

Stanleyson V. Hato;Andrea Khong;I. Jolanda M. de Vries;W. Joost Lesterhuis

472
Citations
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination

Viggo F. van Tendeloo;Ann Van de Velde;Ann van Driessche;Nathalie Cools

460
Citations
Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients

I. Jolanda M. de Vries;W. Joost Lesterhuis;Nicole M. Scharenborg;Linda P. H. Engelen

416
Citations
Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

Jurjen Tel;Erik H.J.G. Aarntzen;Tetsuro Baba;Gerty Schreibelt

409
Citations
Dendritic Cell–Based Immunotherapy: State of the Art and Beyond

Kalijn F. Bol;Gerty Schreibelt;Winald R. Gerritsen;I. Jolanda M. de Vries

385
Citations
Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

W. Joost Lesterhuis;Cornelis J.A. Punt;Stanleyson V. Hato;Dagmar Eleveld-Trancikova

365
Citations
Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production

Friederike Meyer-Wentrup;Daniel Benitez-Ribas;Paul J. Tacken;Cornelis J. A. Punt

362
Citations
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

Gerty Schreibelt;Jurjen Tel;Kwinten H. E. W. J. Sliepen;Daniel Benitez-Ribas

359
Citations
Customizing poly(lactic-co-glycolic acid) particles for biomedical applications

Edyta Swider;Olga Koshkina;Jurjen Tel;Luis J. Cruz

336
Citations
Migrating into the Tumor: a Roadmap for T Cells.

Lieke L. van der Woude;Mark A.J. Gorris;Altuna Halilovic;Carl G. Figdor

324
Citations
19)F MRI for quantitative in vivo cell tracking.

Mangala Srinivas;Arend Heerschap;Eric T. Ahrens;Carl G. Figdor

322
Citations
The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells.

Gerty Schreibelt;Lieke J J Klinkenberg;Luis J Cruz;Paul J Tacken

319
Citations
Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?

Joannes F M Jacobs;Stefan Nierkens;Carl G Figdor;I Jolanda M de Vries

315
Citations
Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors

Joannes F.M. Jacobs;Albert J. Idema;Kalijn F. Bol;Stefan Nierkens

287
Citations
Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients

Joannes F.M. Jacobs;Cornelis J.A. Punt;W. Joost Lesterhuis;Roger P.M. Sutmuller

278
Citations

Frequent Co-Authors

Carl G. Figdor Radboud University

Gerty Schreibelt Radboud University

Gosse J. Adema Radboud University

Cornelis J. A. Punt University of Amsterdam

Ruurd Torensma Radboud University

Winald R. Gerritsen Radboud University

Wim J.G. Oyen Humanitas University

Arend Heerschap Radboud University

Otto C. Boerman Radboud University

Evelien Smits University of Antwerp

External Links

Personal website of I. Jolanda M. de Vries

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Pursuing a degree in immunology opens diverse career opportunities, many of which overlap with nursing and healthcare fields. For those interested in advancing clinical expertise, programs such as accelerated RN to NP programs offer a streamlined pathway to becoming a nurse practitioner, allowing registered nurses to deepen their scope of practice quickly.

For nurses looking to specialize, transitioning between roles can be crucial. For example, if you are a family nurse practitioner (FNP) aiming to work in hospital settings, obtaining the FNP to acute care certification can open doors to acute and critical care environments.

Even those without a nursing background can enter the healthcare field through online ABSN programs for non nurses. These programs enable career changers to earn a Bachelor of Science in Nursing online, providing flexibility and accessibility.

Salary expectations also vary by location and specialization. Understanding how much does a DNP make across states can help in making informed decisions about career goals and potential financial rewards in advanced nursing roles.